FAT1 emerged as one of the top three mutant genes in HNSCC, with significantly higher mutation frequency in HPV‐negative (‐) tumor subtype compared with HPV‐positive (+) tumor subtype (20.08% vs. 0.76%) in TCGA HNSCC cohort (Figure 1B). This evidence concerns the gene FAT1 and neoplasm.